查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1848389

生物技術原料市場預測至2032年：按產品類型、來源、生產方法、應用、最終用戶和地區分類的全球分析

Biotech Ingredients Market Forecasts to 2032 - Global Analysis By Type, Source, Production Method, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計 2025 年全球生技原料市場規模將達到 26.1 億美元，到 2032 年將達到 50.3 億美元，預測期內複合年成長率為 9.8%。

生物技術成分是指利用先進生物技術（例如發酵、酵素催化和基因改造）生產的成分。它們廣泛應用於食品、醫藥、化妝品和農業領域，以提升產品性能、營養價值和安全性。透過利用細胞、微生物和酶，這些成分能夠開發出功能性強、生物活性高且環境永續的產品，為傳統的化學生產方法提供了高效且創新的替代方案。

對機能性食品和營養補充劑的需求日益成長

全球健康意識的增強推動了機能性食品和膳食補充劑中生物技術衍生成分的需求。這些成分提供針對性的健康益處，包括增強免疫力、消化器官系統健康和平衡新陳代謝，因此被納入日常飲食中。生物技術的創新使得胜肽、酵素和益生菌等成分的精準配比成為可能，從而提高了功效。個人化營養趨勢和預防性醫療保健模式正在加速食品飲料產業的普及。監管機構對健康聲明和潔淨標示配方的支持也增強了市場信心。隨著消費者尋求天然、科學的解決方案，生物技術成分正成為下一代健康產品的核心。

高昂的生產和研發成本

最佳化產量、生物利用度和安全性需要先進的研發投入，通常需要數年時間。從實驗室到商業化生產的規模化生產面臨技術難題和成本效率低下的問題。監管合規，包括臨床檢驗和安全性核准，進一步加重了企業的財務負擔。智慧財產權保護和專利申請也增加了主導企業的營運成本。這些挑戰阻礙了中小企業的發展，並延緩了新型成分的上市時間。因此，許多公司正在採取分階段開發策略或尋求合作夥伴關係來降低財務風險。

酵素和微生物技術的創新

客製化酵素正在提升原料生產的反應特異性、穩定性和可擴展性。包括基因工程菌株在內的微生物平台正被最佳化，用於高產率生物合成維生素、胺基酸和生物活性胜肽。這些技術減少了對化學合成的依賴，並支持永續的生產方式。人工智慧和生物資訊學的融合正在加速菌株篩選和製程最佳化。Start-Ups和研究機構正在合作，將新型微生物途徑商業化，應用於特定領域。這波創新浪潮有望重塑原料組合，並擴大食品、製藥和化妝品產業的市場進入。

來自合成替代品的激烈競爭

現有化學品製造商利用規模經濟和精簡的供應鏈來降低生技產品的價格。在某些情況下，合成替代品的功能與生物技術產品相當，這使得價格較高的生物技術產品難以獲得市場認可。關於天然與合成標籤的監管不確定性進一步加劇了消費者認知的混亂。市場宣傳和品牌定位在影響消費者偏好發揮關鍵作用。如果生物技術成分在功效或永續性方面沒有明顯的差異，就有可能被市場拒之門外。持續創新和透明溝通對於抵禦合成替代品的衝擊，捍衛市場佔有率至關重要。

新冠疫情的影響：

新冠疫情再形成了生物技術原料的研發重點，將重點轉向免疫力、衛生和韌性。支持呼吸系統健康、緩解壓力和具有抗病毒特性的原料需求激增。供應鏈中斷影響了原料可得性，並延誤了生產計劃。各公司加速數位轉型，採用遠距研發工具和雲端基礎的協作平台。然而，預算重新分配和營運限制阻礙了非必需創新專案的進展。後疫情時代的策略重點轉向敏捷性、健康防範和多元化採購，以應對未來的挑戰。

預計在預測期內，單株抗體細分市場將是最大的細分市場。

由於單株抗體在治療和診斷藥物中的廣泛應用，預計在預測期內，單株抗體領域將佔據最大的市場佔有率。這些生物製藥具有高度特異性和療效，能夠針對疾病通路，使其成為現代醫學不可或缺的一部分。生物技術的進步提高了抗體的穩定性、擴充性和遞送機制。自體免疫疾病、癌症和感染疾病的日益普遍正在推動對抗體療法的需求。製藥公司正大力投資單株抗體研發管線和生物相似藥的開發。監管核准和報銷機制也為市場擴張提供了支持。

預計在預測期內，化妝品製造商板塊將實現最高的複合年成長率。

在預測期內，受清潔、功能性和生物活性配方需求的推動，化妝品製造商預計將實現最高成長率。消費者越來越傾向於選擇具有科學檢驗功效的護膚和個人保健產品。胜肽、酵素和發酵萃取物等生物技術成分具有抗衰老、保濕和增強皮膚屏障的功效。遞送系統和包封技術的創新正在提升成分的性能和穩定性。各大品牌正利用生物技術在競爭激烈的市場中脫穎而出，並符合安全性和功效的監管標準。社群媒體和網紅行銷正在提升消費者對生技化妝品的認知度。

佔比最大的地區：

在預測期內，亞太地區預計將佔據最大的市場佔有率，這主要得益於其強大的製造業生態系統和日益增強的健康意識。中國、印度、日本和韓國等國家正在增加對生物技術基礎設施和研發能力的投入。傳統醫學的融合以及膳食補充劑的消費正在推動對天然和功能性成分的需求。政府支持生物技術創新和出口競爭力的措施正在促進市場成長。都市化和可支配收入的增加正在擴大消費者獲得優質健康產品的管道。區域內企業正在建立策略聯盟，以擴大生產和分銷。

複合年成長率最高的地區：

預計在預測期內，北美將呈現最高的複合年成長率，這主要得益於前沿研究和健全的法規結構。美國和加拿大擁有眾多領先的生物技術公司和學術機構，它們正推動原料創新。消費者對透明度、永續性和功效的需求正在影響產品開發策略。創業投資和聯邦政府的資助正在支持專注於新型生物合成途徑的新興企業。該地區對個人化營養和預防性醫療保健的重視正在推動生物技術原料的應用。製藥、食品和化妝品產業之間的策略合作正在促進跨產業創新。

免費客製化服務：

訂閱本報告的用戶可享有以下免費客製化服務之一：

  • 公司簡介
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球生技原料市場（按類型分類）

  • 活性藥物成分（API）
  • 生物相似藥
  • 核酸
  • 酵素
  • 胜肽
  • 單株抗體
  • 多醣
  • 其他類型

6. 全球生物技術原料市場（供應商）

  • 微生物
  • 動物
  • 植物
  • 藻類
  • 其他資訊來源

7. 全球生技原料市場依生產方法分類

  • 發酵
  • 從自然資源中提取資源
  • 重組DNA技術
  • 合成生物學
  • 細胞培養技術

8. 全球生技原料市場（依應用領域分類）

  • 製藥
  • 農業和動物飼料
  • 個人護理及化妝品
  • 工業生物技術
  • 食品/飲料
  • 營養補充品
  • 其他用途

9. 全球生物技術原料市場（依最終用戶分類）

  • 製藥和生物製藥公司
  • 契約製造組織（CMO）
  • 化妝品製造商
  • 研究機構
  • 食品加工公司
  • 其他最終用戶

第10章：全球生技原物料市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第12章 企業概況

  • Novozymes A/S
  • DuPont
  • dsm-firmenich
  • Novus International, Inc.
  • AB Enzymes GmbH
  • Evonik Industries AG
  • BASF SE
  • Amyris, Inc.
  • Givaudan
  • Ginkgo Bioworks
  • Chr. Hansen Holding A/S
  • Codexis, Inc.
  • Kerry Group plc
  • Lonza Group
  • Corbion NV
Product Code: SMRC31638

According to Stratistics MRC, the Global Biotech Ingredients Market is accounted for $2.61 billion in 2025 and is expected to reach $5.03 billion by 2032 growing at a CAGR of 9.8% during the forecast period. Biotech ingredients are components produced using advanced biotechnological techniques such as fermentation, enzyme catalysis, or genetic modification. They are utilized across sectors including food, pharma, cosmetics, and agriculture to enhance product performance, nutritional content, and safety. These ingredients allow for the development of functional, bioactive, and environmentally sustainable products by employing cells, microbes, or enzymes, offering an efficient and innovative alternative to conventional chemical-based production methods.

Market Dynamics:

Driver:

Rising demand for functional foods and nutraceuticals

The global surge in health-conscious consumers is propelling demand for biotech-derived ingredients in functional foods and nutraceuticals. These ingredients offer targeted health benefits, such as immune support, digestive wellness, and metabolic balance, driving their inclusion in daily diets. Biotech innovations are enabling precise formulation of ingredients like peptides, enzymes, and probiotics to enhance efficacy. Personalized nutrition trends and preventive healthcare models are accelerating adoption across food and beverage sectors. Regulatory support for health claims and clean-label formulations is also boosting market confidence. As consumers seek natural, science-backed solutions, biotech ingredients are becoming central to next-gen wellness products.

Restraint:

High production and R&D costs

Advanced R&D is required to optimize yield, bioavailability, and safety, often demanding multi-year investments. Scaling up from lab to commercial production introduces technical hurdles and cost inefficiencies. Regulatory compliance, including clinical validation and safety approvals, adds further financial strain. Intellectual property protection and patent filings increase overhead for innovation-driven firms. These challenges deter smaller players and slow down time-to-market for novel ingredients. As a result, many companies adopt phased development strategies or seek partnerships to mitigate financial risks.

Opportunity:

Innovations in enzyme and microbial technology

Tailored enzymes are improving reaction specificity, stability, and scalability in ingredient production. Microbial platforms, including genetically modified strains, are being optimized for high-yield biosynthesis of vitamins, amino acids, and bioactive peptides. These technologies reduce reliance on chemical synthesis and support sustainable manufacturing practices. Integration with AI and bioinformatics is accelerating strain selection and process optimization. Startups and research institutions are collaborating to commercialize novel microbial pathways for niche applications. This wave of innovation is expected to reshape ingredient portfolios and expand market access across food, pharma, and cosmetic sectors.

Threat:

Intense competition from synthetic alternatives

Established chemical manufacturers leverage economies of scale and streamlined supply chains to undercut biotech pricing. In some cases, synthetic versions offer comparable functionality, making it difficult to justify premium biotech options. Regulatory ambiguity around natural vs. synthetic labeling further blurs consumer perception. Marketing claims and brand positioning play a critical role in influencing buyer preferences. Without clear differentiation in efficacy or sustainability, biotech ingredients risk being sidelined. Continuous innovation and transparent communication are essential to defend market share against synthetic substitutes.

Covid-19 Impact:

The COVID-19 pandemic reshaped priorities in biotech ingredient development, emphasizing immunity, hygiene, and resilience. Demand surged for ingredients supporting respiratory health, stress reduction, and antiviral properties. Supply chain disruptions affected raw material availability and delayed production timelines. Companies accelerated digital transformation, adopting remote R&D tools and cloud-based collaboration platforms. However, budget reallocations and operational constraints slowed non-essential innovation pipelines. Post-pandemic strategies now focus on agility, health preparedness, and diversified sourcing to withstand future disruptions.

The monoclonal antibodies segment is expected to be the largest during the forecast period

The monoclonal antibodies segment is expected to account for the largest market share during the forecast period, due to its widespread application in therapeutic and diagnostic products. These biologics offer high specificity and efficacy in targeting disease pathways, making them indispensable in modern medicine. Biotech advancements have improved antibody stability, scalability, and delivery mechanisms. Growing prevalence of autoimmune disorders, cancers, and infectious diseases is driving demand for antibody-based treatments. Pharmaceutical companies are investing heavily in monoclonal antibody pipelines and biosimilar development. Regulatory approvals and reimbursement frameworks are supporting market expansion.

The cosmetic manufacturers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetic manufacturers segment is predicted to witness the highest growth rate, driven by demand for clean, functional, and bioactive formulations. Consumers are increasingly seeking skincare and personal care products with scientifically validated benefits. Biotech ingredients such as peptides, enzymes, and fermented extracts offer anti-aging, hydration, and skin barrier support. Innovations in delivery systems and encapsulation are enhancing ingredient performance and shelf stability. Brands are leveraging biotech to differentiate in a crowded market and meet regulatory standards for safety and efficacy. Social media and influencer marketing are amplifying awareness of biotech-based cosmetics.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fueled by robust manufacturing ecosystems and rising health awareness. Countries like China, India, Japan, and South Korea are investing in biotech infrastructure and R&D capabilities. Traditional medicine integration and dietary supplement consumption are driving demand for natural and functional ingredients. Government initiatives supporting biotech innovation and export competitiveness are accelerating market growth. Urbanization and rising disposable incomes are expanding consumer access to premium wellness products. Regional players are forming strategic alliances to scale production and distribution.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, propelled by cutting-edge research and strong regulatory frameworks. The U.S. and Canada are home to leading biotech firms and academic institutions driving ingredient innovation. Consumer demand for transparency, sustainability, and efficacy is shaping product development strategies. Venture capital and federal funding are supporting startups focused on novel biosynthesis pathways. The region's emphasis on personalized nutrition and preventive healthcare is boosting biotech ingredient adoption. Strategic collaborations between pharma, food, and cosmetic sectors are fostering cross-industry innovation.

Key players in the market

Some of the key players in Biotech Ingredients Market include Novozymes A/S, DuPont, dsm-firmenich, Novus International, Inc., AB Enzymes GmbH, Evonik Industries AG, BASF SE, Amyris, Inc., Givaudan, Ginkgo Bioworks, Chr. Hansen Holding A/S, Codexis, Inc., Kerry Group plc, Lonza Group, and Corbion N.V.

Key Developments:

In September 2025, DuPont has signed an agreement to acquire Sinochem RO Memtech Co., Ltd. to expand its reverse osmosis (RO) manufacturing footprint into China and the Asia Pacific region. With advanced membrane and fabrication production technologies, the acquisition increases DuPont's capacity to meet the growing demand in the region for FilmTec(TM) elements for industrial water purification and reuse.

In September 2025, dsm-firmenich launches four new Dairy Safe(TM) culture rotations. These all-in-one, label-friendly solutions deliver assured bioprotection through improved phage robustness as well as greater temperature resistance, controlled eye formation, consistent acidification, and enhanced flavor development for premium semi-hard, hard, and continental-style cheese varieties.

Types Covered:

  • Active Pharmaceutical Ingredients (APIs)
  • Biosimilars
  • Nucleic Acids
  • Enzymes
  • Peptides
  • Monoclonal Antibodies
  • Polysaccharides
  • Other Types

Sources Covered:

  • Microbial
  • Animal
  • Plant
  • Algae
  • Other Sources

Production Methods Covered:

  • Fermentation
  • Extraction from Natural Sources
  • Recombinant DNA Technology
  • Synthetic Biology
  • Cell Culture Technology

Applications Covered:

  • Pharmaceuticals
  • Agriculture & Animal Feed
  • Personal Care & Cosmetics
  • Industrial Biotechnology
  • Food & Beverages
  • Nutraceuticals
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Cosmetic Manufacturers
  • Research Institutes
  • Food Processing Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biotech Ingredients Market, By Type

  • 5.1 Introduction
  • 5.2 Active Pharmaceutical Ingredients (APIs)
  • 5.3 Biosimilars
  • 5.4 Nucleic Acids
  • 5.5 Enzymes
  • 5.6 Peptides
  • 5.7 Monoclonal Antibodies
  • 5.8 Polysaccharides
  • 5.9 Other Types

6 Global Biotech Ingredients Market, By Source

  • 6.1 Introduction
  • 6.2 Microbial
  • 6.3 Animal
  • 6.4 Plant
  • 6.5 Algae
  • 6.6 Other Sources

7 Global Biotech Ingredients Market, By Production Method

  • 7.1 Introduction
  • 7.2 Fermentation
  • 7.3 Extraction from Natural Sources
  • 7.4 Recombinant DNA Technology
  • 7.5 Synthetic Biology
  • 7.6 Cell Culture Technology

8 Global Biotech Ingredients Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceuticals
  • 8.3 Agriculture & Animal Feed
  • 8.4 Personal Care & Cosmetics
  • 8.5 Industrial Biotechnology
  • 8.6 Food & Beverages
  • 8.7 Nutraceuticals
  • 8.8 Other Applications

9 Global Biotech Ingredients Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical & Biopharmaceutical Companies
  • 9.3 Contract Manufacturing Organizations (CMOs)
  • 9.4 Cosmetic Manufacturers
  • 9.5 Research Institutes
  • 9.6 Food Processing Companies
  • 9.7 Other End Users

10 Global Biotech Ingredients Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Novozymes A/S
  • 12.2 DuPont
  • 12.3 dsm-firmenich
  • 12.4 Novus International, Inc.
  • 12.5 AB Enzymes GmbH
  • 12.6 Evonik Industries AG
  • 12.7 BASF SE
  • 12.8 Amyris, Inc.
  • 12.9 Givaudan
  • 12.10 Ginkgo Bioworks
  • 12.11 Chr. Hansen Holding A/S
  • 12.12 Codexis, Inc.
  • 12.13 Kerry Group plc
  • 12.14 Lonza Group
  • 12.15 Corbion N.V.

List of Tables

  • Table 1 Global Biotech Ingredients Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biotech Ingredients Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Biotech Ingredients Market Outlook, By Active Pharmaceutical Ingredients (APIs) (2024-2032) ($MN)
  • Table 4 Global Biotech Ingredients Market Outlook, By Biosimilars (2024-2032) ($MN)
  • Table 5 Global Biotech Ingredients Market Outlook, By Nucleic Acids (2024-2032) ($MN)
  • Table 6 Global Biotech Ingredients Market Outlook, By Enzymes (2024-2032) ($MN)
  • Table 7 Global Biotech Ingredients Market Outlook, By Peptides (2024-2032) ($MN)
  • Table 8 Global Biotech Ingredients Market Outlook, By Monoclonal Antibodies (2024-2032) ($MN)
  • Table 9 Global Biotech Ingredients Market Outlook, By Polysaccharides (2024-2032) ($MN)
  • Table 10 Global Biotech Ingredients Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 11 Global Biotech Ingredients Market Outlook, By Source (2024-2032) ($MN)
  • Table 12 Global Biotech Ingredients Market Outlook, By Microbial (2024-2032) ($MN)
  • Table 13 Global Biotech Ingredients Market Outlook, By Animal (2024-2032) ($MN)
  • Table 14 Global Biotech Ingredients Market Outlook, By Plant (2024-2032) ($MN)
  • Table 15 Global Biotech Ingredients Market Outlook, By Algae (2024-2032) ($MN)
  • Table 16 Global Biotech Ingredients Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 17 Global Biotech Ingredients Market Outlook, By Production Method (2024-2032) ($MN)
  • Table 18 Global Biotech Ingredients Market Outlook, By Fermentation (2024-2032) ($MN)
  • Table 19 Global Biotech Ingredients Market Outlook, By Extraction from Natural Sources (2024-2032) ($MN)
  • Table 20 Global Biotech Ingredients Market Outlook, By Recombinant DNA Technology (2024-2032) ($MN)
  • Table 21 Global Biotech Ingredients Market Outlook, By Synthetic Biology (2024-2032) ($MN)
  • Table 22 Global Biotech Ingredients Market Outlook, By Cell Culture Technology (2024-2032) ($MN)
  • Table 23 Global Biotech Ingredients Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Biotech Ingredients Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 25 Global Biotech Ingredients Market Outlook, By Agriculture & Animal Feed (2024-2032) ($MN)
  • Table 26 Global Biotech Ingredients Market Outlook, By Personal Care & Cosmetics (2024-2032) ($MN)
  • Table 27 Global Biotech Ingredients Market Outlook, By Industrial Biotechnology (2024-2032) ($MN)
  • Table 28 Global Biotech Ingredients Market Outlook, By Food & Beverages (2024-2032) ($MN)
  • Table 29 Global Biotech Ingredients Market Outlook, By Nutraceuticals (2024-2032) ($MN)
  • Table 30 Global Biotech Ingredients Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 Global Biotech Ingredients Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Biotech Ingredients Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 33 Global Biotech Ingredients Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 34 Global Biotech Ingredients Market Outlook, By Cosmetic Manufacturers (2024-2032) ($MN)
  • Table 35 Global Biotech Ingredients Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 36 Global Biotech Ingredients Market Outlook, By Food Processing Companies (2024-2032) ($MN)
  • Table 37 Global Biotech Ingredients Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.